Deccan Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-11-2024
- Paid Up Capital ₹ 1.60 M
as on 16-11-2024
- Company Age 22 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.30 Cr
as on 16-11-2024
- Revenue 0.79%
(FY 2023)
- Profit 38.29%
(FY 2023)
- Ebitda -35.11%
(FY 2023)
- Net Worth 2.81%
(FY 2023)
- Total Assets -27.08%
(FY 2023)
About Deccan Life Sciences
The Corporate was formerly known as Oriental Healthcare Specialities P Ltd. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.60 M.
The company currently has active open charges totaling ₹6.30 Cr.
Kanchan Bihani and Bijay Bihani serve as directors at the Company.
- CIN/LLPIN
U33112KA2002PTC030122
- Company No.
030122
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Feb 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- LocationBangalore., Karnataka
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Deccan Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kanchan Bihani  | Director | 14-Feb-2002 | Current |
| Bijay Bihani | Director | 14-Feb-2002 | Current |
Financial Performance and Corporate Structure Insights of Deccan Life Sciences.
Deccan Life Sciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.79% increase. The company also saw a substantial improvement in profitability, with a 38.29% increase in profit. The company's net worth moved up by a moderate rise of 2.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Deccan Life Sciences?
In 2023, Deccan Life Sciences had a promoter holding of 31.19% and a public holding of 68.81%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sasvat Omnicare Private LimitedActive 9 years 3 monthsKanchan Bihani and Bijay Bihani are mutual person
Snapshot Barter Private LimitedActive 19 years 3 monthsKanchan Bihani and Bijay Bihani are mutual person
- Radiant Healthcare Private LimitedActive 16 years 11 months
Kanchan Bihani and Bijay Bihani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 29 Mar 2004 | ₹6.30 Cr | Open |
How Many Employees Work at Deccan Life Sciences?
Unlock and access historical data on people associated with Deccan Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Deccan Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deccan Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
